Daniel Becerril/Reuters
- Amazon just signaled its intent to get into the pharmaceutical business through the acquisition of a startup called PillPack.
- The deal came just a few months after Walmart was reported to be thinking of buying PillPack. Walmart lost about $3 billion in market cap on Thursday after Amazon announced it had bought the pharmacy startup.
- That impact to Walmart's valuation over a reported $1 billion deal shows how intense the rivalry between the two retail giants has gotten.
Amazon threw the entire pharmacy industry into a tizzy last week when it announced its plans to acquire PillPack, a small startup that mails prescriptions to people who take multiple medications.
Among the companies hit: chief rival Walmart, which lost about $3 billion in market cap after the deal was announced.
See the rest of the story at Business Insider
NOW WATCH: Why Rolex watches are so expensive
See Also:
- Bed Bath & Beyond customers are starting not to care about the best reason to shop there
- Amazon merged 2 of its most important teams, and it reflects a huge evolution for the company
- Amazon Prime Day, a made-up holiday that's become bigger than Black Friday, is coming soon. Here's why it's such a big deal.
SEE ALSO: Walmart and Amazon could be readying for war over a growing chunk of the US population
from Business Insider https://ift.tt/2yVrW2J
No comments:
Post a Comment